A
Angelo Branzi
Researcher at University of Bologna
Publications - 350
Citations - 17546
Angelo Branzi is an academic researcher from University of Bologna. The author has contributed to research in topics: Atrial fibrillation & Heart failure. The author has an hindex of 58, co-authored 350 publications receiving 16425 citations.
Papers
More filters
Journal ArticleDOI
Predictors of 32P β brachytherapy failure in patients with high-risk in-stent restenosis
Paolo Ortolani,Antonio Marzocchi,Matteo Aquilina,William Gaiba,Feisal Bunkheila,Stefano Neri,Enzo Lombardo,Cinzia Marrozzini,Stefania Pini,Nevio Taglieri,Paolo Sbarzaglia,Maria Letizia Bacchi Reggiani,Enza Barbieri,Angelo Branzi +13 more
TL;DR: It is indicated that 7-month angiographic restenosis after (32)P IRT in complex patients with ISR is not a frequent event and is predicted mainly by an occlusive lesion at baseline and by procedural geographical miss.
Book ChapterDOI
Cost-Effectiveness and Aspects of Health Economics in Primary Prevention: What Is the Case of Dilated Cardiomyopathy?
Giuseppe Boriani,Mauro Biffi,Cristian Martignani,Cinzia Valzania,Igor Diemberger,Matteo Ziacchi,Davide Saporito,P Artale,Matteo Bertini,Claudio Rapezzi,Angelo Branzi +10 more
TL;DR: Cost-effectiveness analysis provides the most appropriate tool for weighing costs against benefits for both ICD and CRT-D and should be directed towards specifically defined subsets of patients, including those with non-ischaemic cardiomyopathy.
Journal ArticleDOI
Potential of Medical Treatment, Device Therapy, and Conventional Surgery in Patients Referred for Heart Transplantation
Francesco Grigioni,Luciano Potena,Antonio Russo,Giuseppe Boriani,Marco Masetti,Gaia Magnani,Fabio Coccolo,Francesco Fallani,Angelo Branzi +8 more
TL;DR: The increasing shortage of donors for heart transplantation (HT) imposes the need to maximize the potential of alternative and complementary therapeutic options, and the potential for enhancing medical therapy and selecting conventional surgical strategies among patients referred to a heart-failure management unit for HT is investigated.
Journal Article
Prognostic value of echocardiographic parameters in patients with pulmonary arterial hypertension (PAH) treated with targeted therapies
Elena Beciani,Massimiliano Palazzini,Cristina Bachetti,Federica Sgrò,Elisa Conficoni,Enrico Gotti,Gaia Mazzanti,Alessandra Manes,Angelo Branzi,N Galie +9 more